Transgenic plants: a 5-year update on oral antipathogen vaccine development

References

• Curtiss R 3rd, Cardineau GA. US5679880 A; 1997
   Google Scholar
• Bock R. Engineering chloroplasts for high-level foreign protein expression. Methods Mol Biol 2014;1132:93-106
   PubMedGoogle Scholar
• Jacob SS, Cherian S, Sumithra TG, et al. Edible vaccines against veterinary parasitic diseases--current status and future prospects. Vaccine 2013;31(15):1879-85
   PubMed Web of Science ®Google Scholar
• Rosales-Mendoza S, Salazar-González JA. Immunological aspects of using plant cells as delivery vehicles for oral vaccines. Expert Rev Vaccines. 2014. [Epub ahead of print]
   Google Scholar
• Specht EA, Mayfield SP. Algae-based oral recombinant vaccines. Front Microbiol 2014;5:60
   PubMed Web of Science ®Google Scholar
• Guan ZJ, Guo B, Huo YL, et al. Recent advances and safety issues of transgenic plant-derived vaccines. Appl Microbiol Biotechnol 2013;97(7):2817-40
   PubMed Web of Science ®Google Scholar
• Ahmad A, Pereira EO, Conley AJ, et al. Green biofactories: recombinant protein production in plants. Recent Pat Biotechnol 2010;4(3):242-59
   PubMedGoogle Scholar
• Lugade AA, Kalathil S, Heald JL, Thanavala Y. Transgenic plant-based oral vaccines. Immunol Invest 2010;39(4-5):468-82
   PubMed Web of Science ®Google Scholar
• Kim SH, Jang YS. Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines. Exp Mol Med 2014;46:e85
   PubMed Web of Science ®Google Scholar
• Meeusen EN. Exploiting mucosal surfaces for the development of mucosal vaccines. Vaccine 2011;29(47):8506-11
   PubMed Web of Science ®Google Scholar
• Owen JL, Sahay B, Mohamadzadeh M. New generation of oral mucosal vaccines targeting dendritic cells. Curr Opin Chem Biol 2013;17(6):918-24
   PubMed Web of Science ®Google Scholar
• Pavot V, Rochereau N, Genun C, et al. New insights in mucosal vaccine development. Vaccine 2012;30(2):142-54
   PubMed Web of Science ®Google Scholar
• Gupta PN, Vyas SP. Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization. Colloids Surf B Biointerfaces 2011;82(1):118-25
   PubMed Web of Science ®Google Scholar
• Otczky DC, Cripps AW. Mucosal immunization: a realistic alternative. Hum Vacinn 2010;6(12):978-1006
   PubMedGoogle Scholar
• Fujihashi K, Kato H, van Ginkel FW, et al. A revisit of mucosal IgA immunity and oral tolerance. Acta Odontol Scand 2001;59(5):301-8
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Pascual DW, Kiyono H. M cell-targeted mucosal vaccine strategies. Curr Top Microbiol Immunol 2012;354:39-52
   PubMed Web of Science ®Google Scholar
• Fujkuyama Y, Tokuhara D, Hataoka K, et al. Novel vaccine development strategies for inducing mucosal immunity. Expert Rev Vaccines 2012;11(3):367-79
   PubMed Web of Science ®Google Scholar
• Mason HS, Herbst-Kralovetz MM. Plant-derived antigens as mucosal vaccines. Curr Top Microbiol Immunol 2012;354:101-20
   PubMed Web of Science ®Google Scholar
• Pniewski T. The twenty-year story of a plant-based vaccine against hepatitis B: stagnation or promising prospects? Int J Mol Sci 2013;14(1):1978-98
   PubMed Web of Science ®Google Scholar
• Kwon KC, Verma D, Singh ND, et al. Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv Drug Deliv Rev 2013;65(6):782-99
   PubMed Web of Science ®Google Scholar
• Boothe JG, Saponja JA, Parmenter DL. Molecular farming in plants: oilseeds as vehicles for the production of pharmaceutical proteins. Drug Dev Res 1997;42(3-4):172-81
   Web of Science ®Google Scholar
• Karg SR, Kallio PT. The production of biopharmaceuticals in plant systems. Biotechnol Adv 2009;27(6):879-94
   PubMed Web of Science ®Google Scholar
• Khan I, Twyman RM, Arcalis E, Stoger E. Using storage organelles for the accumulation and encapsulation of recombinant proteins. Biotechnol J 2012;7(9):1099-108
   PubMed Web of Science ®Google Scholar
• Lamphear BJ, Streatfield SJ, Jilka JM, et al. Delivery of subunit vaccines in maize seed. J Control Release 2002;85(1-3):169-80
   PubMed Web of Science ®Google Scholar
• Bock R. Genetic engineering of the chloroplast: novel tools and new applications. Curr Opin Biotechnol 2014;26:7-13
   PubMed Web of Science ®Google Scholar
• Oey M, Lohse M, Kreikemeyer B, Bock R. Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J 2009;57(3):436-45
   PubMed Web of Science ®Google Scholar
• Hagemann R. The sexual inheritance of plant organelles. In: Daniell H, Chase C, editors. Molecular biology and biotechnology of plant organelles. Springer Publishers; The Netherlands: 2004. p. 93-113
   Google Scholar
• Maliga P. Plastid transformation in higher plants. Annu Rev Plant Biol 2004;55:289-313
   PubMed Web of Science ®Google Scholar
• Arai Y, Shikanai T, Doi Y, et al. Production of polyhydroxybutyrate by polycistronic expression of bacterial genes in tobacco plastid. Plant Cell Physiol 2004;45(9):1176-84
   PubMed Web of Science ®Google Scholar
• Scharff LB, Bock R. Emerging tools for synthetic biology in plants. Plant J 2013. [ Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Oliveira PH, Mairhofer J. Marker-free plasmids for biotechnological applications – implications and perspectives. Trends Biotechnol 2013;31(9):539-47
   PubMed Web of Science ®Google Scholar
• Li B, Xie C, Qiu H. Production of selectable marker-free transgenic tobacco plants using a non-selection approach: chimerism or escape, transgene inheritance, and efficiency. Plant Cell Rep 2009;28(3):373-86
   PubMed Web of Science ®Google Scholar
• Manimaran P, Ramkumar G, Sakthivel K, et al. Suitability of non-lethal marker and marker-free systems for development of transgenic crop plants: present status and future prospects. Biotechnol Adv 2011;29(6):703-14
   PubMed Web of Science ®Google Scholar
• Penna S, Ganapathi TR. Engineering the plant genome. Prospects of selection systems using non-antibiotic marker genes. GM Crops 2010;1(3):128-36
   PubMedGoogle Scholar
• Tuteja N, Verma S, Sahoo RK, et al. Recent advances in development of marker-free transgenic plants: regulation and biosafety concern. J Biosci 2012;37(1):167-97
   PubMed Web of Science ®Google Scholar
• Gutiérrez SP, Saberianfar R, Kohalmi SE, Menassa R. Protein body formation in stable transgenic tobacco expressing elastin-like polypeptide and hydrophobin fusion proteins. BMC Biotechnol 2013;10:13-40
   Google Scholar
• Floss DM, Schallau K, Rose-John S, et al. Elastin-like polypeptides revolutionize recombinant protein expression and their biomedical application. Trends Biotechnol 2010;28(1):37-45
   PubMed Web of Science ®Google Scholar
• Conley AJ, Joensuu JJ, Jevnikar AM, et al. Optimization of elastin-like polypeptide fusions for expression and purification of recombinant proteins in plants. Biotechnol Bioeng 2009;103(3):562-73
   PubMed Web of Science ®Google Scholar
• Floss DM, Mockey M, Zanello G, et al. Expression and Immunogenicity of the Mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy. J Biomed Biotechnol 2010;2010:1-14
   Google Scholar
• Phan HT, Pohl J, Floss DM, et al. ELPylated haemagglutinins in tobacco plants induce potentially neutralizing antibodies against H5N1 viruses in mice. Plant Biotechnol J 2013;11(5):582-93
   PubMed Web of Science ®Google Scholar
• Conley AJ, Joensuu JJ, Richman A, Menassa R. Protein body-inducing fusions for high-level production and purification of recombinant proteins in plants. Plant Biotechnol J 2011;9(4):419-33
   PubMed Web of Science ®Google Scholar
• Joensuu JJ, Conley AJ, Lienemann M, et al. Hydrophobin fusion for high-level transient protein expression and purification in Nicotiana Benthamiana. Plant Physiol 2010;152(2):622-33
   PubMed Web of Science ®Google Scholar
• Gleba Y, Marillonnet S, Klimyuk V. Engineering viral expression vectors for plants: the ’full virus’ and the ’deconstructed virus’ strategies. Curr Opin Plant Biol 2004;7(2):182-8
   PubMed Web of Science ®Google Scholar
• Gleba Y, Klimyuk V, Marillonnet S. Magnifection--a new platform for expressing recombinant vaccines in plants. Vaccine 2005;23(17-18):2042-8
   PubMed Web of Science ®Google Scholar
• Landry N, Ward BJ, Trépanier S, et al. Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS One 2010;5(12):e15559
   PubMed Web of Science ®Google Scholar
• Huang Z, Chen Q, Hjelm B, et al. A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnol Bioeng 2009;103(4):706-14
   PubMed Web of Science ®Google Scholar
• Regnard GL, Halley-Stott RP, Tanzer FL, et al. High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector. Plant Biotechnol J 2010;8(1):38-46
   PubMed Web of Science ®Google Scholar
• Yusibov V, Streatfield SJ, Kushnir N, et al. Hybrid viral vectors for vaccine and antibody production in plants. Curr Pharm Des 2013;19(31):5574-86
   PubMed Web of Science ®Google Scholar
• Farmacule (2009). Available from: www.ctcb.qut.edu.au/programs/farmacule.jsp
   Google Scholar
• Rybicki EP. Plant-made vaccines for humans and animals. Plant Biotechnol J 2010;8(5):620-37
   PubMed Web of Science ®Google Scholar
• Peyret H, Lomonossoff GP. The pEAQ vector series: the easy and quick way to produce recombinant proteins in plants. Plant Mol Biol 2013;83(1-2):51-8
   PubMed Web of Science ®Google Scholar
• Sainsbury F, Thuenemann EC, Lomonossoff GP. pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants. Plant Biotechnol J 2009;7(7):682-93
   PubMed Web of Science ®Google Scholar
• Webster DE, Wang L, Mulcair M, et al. Production and characterization of an oral immunogenic Plasmodium antigen in plants using a virus-based expression system. Plant Biotechnol J 2009;7(9):846-55
   PubMed Web of Science ®Google Scholar
• Musiychuk K, Stephenson N, Bi H, et al. A launch vector for the production of vaccine antigens in plants. Influenza Other Respir Viruses 2007;1(1):19-25
   PubMed Web of Science ®Google Scholar
• Massa S, Franconi R, Brandi R, et al. Anti-cancer activity of plant-produced HPV16 E7 vaccine. Vaccine 2007;25(16):3018-21
   PubMed Web of Science ®Google Scholar
• Mett V, Musiychuk K, Bi H, et al. A plant produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Respir Viruses 2008;2(1):33-40
   PubMed Web of Science ®Google Scholar
• Hefferon KL. Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins. Virology 2012;433(1):1-6
   PubMed Web of Science ®Google Scholar
• Fujiki M, Kaczmarczyk JF, Yusibov V, Rabindran S. Development of a new cucumber mosaic virus-based plant expression vector with truncated 3a movement protein. Virology 2008;381(1):136-42
   PubMed Web of Science ®Google Scholar
• López-Macías C. Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic. Hum Vaccinn Immunother 2012;8(3):411-14
   PubMed Web of Science ®Google Scholar
• Chen Q, Lai H. Plant-derived virus-like particles as vaccines. Hum Vaccinn Immunother 2013;9(1):26-49
   PubMed Web of Science ®Google Scholar
• Norja P, Lassila R, Makris M. Parvovirus transmission by blood products - a cause for concern? Br J Haematol 2012;159(4):385-93
   PubMed Web of Science ®Google Scholar
• Vianna GR, Cunha NB, Murad AM, et al. Soybeans as bioreactors for biopharmaceuticals and industrial proteins. Genet Mol Res 2011;10(3):1733-52
   PubMed Web of Science ®Google Scholar
• Karimi F, Mousavi A, Hatef-Salmanian A, et al. Immunogenicity of EIT chimeric protein expressed in transplastomic tobacco plants towards development of an oral vaccine against Escherichia coli O157:H7. Plant Biotechnol Rep 2013;7(4):535-46
   Web of Science ®Google Scholar
• Rubio-Infante N, Govea-Alonso DO, Alpuche-Solís AG, et al. A chloroplast-derived C4V3 polypeptide from the human immunodeficiency virus (HIV) is orally immunogenic in mice. Plant Mol Biol 2012;78(4-5):337-49
   PubMed Web of Science ®Google Scholar
• Peréz Aguirreburualde MS, Gómez MC, Ostachuk A, et al. Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants. Vet Immunol Immunopathol 2013;151(3-4):315-24
   PubMed Web of Science ®Google Scholar
• Hu J, Ni Y, Dryman BA, et al. Immunogenicity study of plant-made oral subunit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV). Vaccine 2012;30(12):2068-74
   PubMed Web of Science ®Google Scholar
• Penney CA, Thomas DR, Deen SS, Walmsley AM. Plant-made vaccines in support of the Millennium Development Goals. Plant Cell Rep 2011;30(5):789-98
   PubMed Web of Science ®Google Scholar
• Medicago Inc. (2013). Available from: www.medicago.com/English/Products/product-pipeline/default.aspx
   Google Scholar
• Melnik S, Stoger E. Green factories for biopharmaceuticals. Curr Med Chem 2013;20(8):1038-46
   PubMed Web of Science ®Google Scholar
• Davies HM. Commercialization of whole-plant systems for biomanufacturing of protein products: evolution and prospects. Plant Biotechnol J 2010;8(8):845-61
   PubMed Web of Science ®Google Scholar
• Scotti N, Rybicki EP. Virus-like particles produced in plants as potential vaccines. Expert Rev Vaccines 2013;12(2):211-24
   PubMed Web of Science ®Google Scholar
• Streatfield SJ. Regulatory issues for plant-made pharmaceuticals and vaccines. Expert Rev Vaccines 2005;4(4):591-601
   PubMed Web of Science ®Google Scholar
• Hefferon K. Plant-derived pharmaceuticals for the developing world. Biotechnol J 2013;8(10):1193-202
   PubMed Web of Science ®Google Scholar
• Rosales-Mendoza S, Govea-Alonso DO, Monreal-Escalante E, et al. Developing plant-based vaccines against neglected tropical diseases: where are we? Vaccine 2012;31(1):40-8
   PubMed Web of Science ®Google Scholar
• Vamvaka E, Twyman RM, Christou P, Capell T. Can plant biotechnology help to break the HIV-malaria link? Biotechnol Adv 2014;32(3):575-82
   PubMed Web of Science ®Google Scholar
• Ruhlman T, Ahangari R, Devine A, et al. Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts – oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol J 2007;5(4):495-510
   PubMed Web of Science ®Google Scholar
• Rosales-Mendoza S. Can a plant-based vaccine treat hypertension? Med Hypotheses 2012;79(5):555-9
   PubMed Web of Science ®Google Scholar
• Salazar-González JA, Rosales-Mendoza S. A perspective for atherosclerosis vaccination: is there a place for plant-based vaccines? Vaccine 2013;31(10):1364-9
   PubMed Web of Science ®Google Scholar
• Zhou B, Zhang Y, Wang X, et al. Oral administration of plant-based rotavirus VP6 induces antigen-specific IgAs, IgGs and passive protection in mice. Vaccine 2010;28(37):6021-7
   PubMed Web of Science ®Google Scholar
• Van Dolleweerd CJ, Teh AY, Banyard AC, et al. Engineering, expression in transgenic plants and characterization of e559, a rabies virus-neutralizing monoclonal antibody. J Infect Dis 2014;210(2):200-8
   PubMed Web of Science ®Google Scholar
• Loza-Rubio E, Rojas-Anaya E, López J, et al. Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein. Vaccine 2012;30(37):5551-6
   PubMed Web of Science ®Google Scholar
• Ganapathy M, Perumal A, Mohan C, et al. Immunogenicity of Brugia malayi abundant larval transcript-2, a potential filarial vaccine candidate expressed in tobacco. Plant Cell Rep 2014;33(1):179-88
   PubMed Web of Science ®Google Scholar
• Uvarova EA, Belavin PA, Permyakova NV, et al. Oral Immunogenicity of plant-made Mycobacterium tuberculosis ESAT6 and CFP10. Biomed Res Int 2013;2013:316304
   PubMed Web of Science ®Google Scholar
• Lakshmi PS, Verma D, Yang X, et al. Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro. PLoS One 2013;8(1):e54708
   PubMed Web of Science ®Google Scholar
• Huy NX, Kim SH, Yang MS, et al. Immunogenicity of a neutralizing epitope from porcine epidemic diarrhea virus: M cell targeting ligand fusion protein expressed in transgenic rice calli. Plant Cell Rep 2012;31(10):1933-42
   PubMed Web of Science ®Google Scholar
• Wang Y, Shen Q, Jiang Y, et al. Immunogenicity of foot-and-mouth disease virus structural polyprotein P1 expressed in transgenic rice. J Virol Methods 2012;181(1):12-17
   PubMed Web of Science ®Google Scholar
• Rao JP, Agrawal P, Mohammad R, et al. Expression of VP1 protein of serotype A and O of foot-and-mouth disease virus in transgenic sunnhemp plants and its immunogenicity for guinea pigs. Acta Virol 2012;56(2):91-9
   PubMed Web of Science ®Google Scholar
• Soria-Guerra RE, Rosales-Mendoza S, Moreno-Fierros L, et al. Oral immunogenicity of tomato-derived sDPT polypeptide containing Corynebacterium diphtheriae, Bordetella pertussis and Clostridium tetani exotoxin epitopes. Plant Cell Rep 2011;30(3):417-24
   PubMed Web of Science ®Google Scholar
• Rukavtsova EB, Chebotareva EN, Rudenko NV, Buryanov YI. Immunogenicity of biologically safe potato tubers synthesizing hepatitis B surface antigen. Dokl Biol Sci 2011;437:110-12
   PubMedGoogle Scholar
• Ghiasi SM, Salmanian AH, Chinikar S, et al. Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus. Clin Vaccine Immunol 2011;18(12):2031-7
   PubMed Web of Science ®Google Scholar
• Shoji Y, Chichester JA, Jones M, et al. Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza. Hum Vaccin 2011;7(Suppl):41-50
   PubMed Web of Science ®Google Scholar
• Govea-Alonso DO, Rubio-Infante N, García-Hernández AL, et al. Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein. Planta 2013;238(4):785-92
   PubMed Web of Science ®Google Scholar
• Hongli L, Xukui L, Ting L, et al. Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice. Hum Vaccin Immunother 2013;9(1):83-9
   PubMed Web of Science ®Google Scholar
• Rossi L, Dell’orto V, Vagni S, et al. Protective effect of oral administration of transgenic tobacco seeds against verocytotoxic Escherichia coli strain in piglets. Vet Res Commun 2014;38(1):39-49
   PubMed Web of Science ®Google Scholar
• Pasquevich KA, Ibañez AE, Coria LM, et al. An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice. PLoS One 2011;6(1):e16203
   PubMed Web of Science ®Google Scholar
• Gregory JA, Topol AB, Doerner DZ, et al. Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines. Appl Environ Microbiol 2013;79(13):3917-25
   PubMed Web of Science ®Google Scholar
• Yiu JC, Liu CW, Su RY, et al. Immunogenicity of a lettuce-derived vaccine candidate expressing the E2 protein against classical swine fever virus. Plant Cell Tiss Organ Cult 2013;113(3):483-90
   Web of Science ®Google Scholar
• Festa M, Brun P, Piccinini R, et al. Staphylococcus aureus Efb protein expression in Nicotiana tabacum and immune response to oral administration. Res Vet Sci 2013;94(3):484-9
   PubMed Web of Science ®Google Scholar
• Hamorsky KT, Kouokam JC, Bennett LJ, et al. Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks. PLoS Negl Trop Dis 2013;7(3):e2046
   PubMed Web of Science ®Google Scholar
• Karaman S, Cunnick J, Wang K. Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler’s diarrhea. Plant Cell Rep 2012;31(3):527-37
   PubMed Web of Science ®Google Scholar
• Davoodi-Semiromi A, Schreiber M, Nalapalli S, et al. Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. Plant Biotechnol J 2010;8(2):223-42
   PubMed Web of Science ®Google Scholar
• Zhang XX, Yu H, Wang XH, et al. Protective efficacy against Chlamydophila psittaci by oral immunization based on transgenic rice expressing MOMP in mice. Vaccine 2013;31(4):698-703
   PubMed Web of Science ®Google Scholar
• Betancourt MA, de Aluja AS, Sciutto E, et al. Effective protection induced by three different versions of the porcine S3Pvac anticysticercosis vaccine against rabbit experimental Taenia pisiformis cysticercosis. Vaccine 2012;30(17):2760-7
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen S, Li J, et al. Oral immunogenicity of potato-derived antigens to Mycobacterium tuberculosis in mice. Acta Biochim Biophys Sin (Shanghai) 2012;44(10):823-30
   PubMed Web of Science ®Google Scholar
• Del L, Yácono M, Farran I, et al. A chloroplast-derived Toxoplasma gondii GRA4 antigen used as an oral vaccine protects against toxoplasmosis in mice. Plant Biotechnol J 2012;10(9):1136-44
   PubMed Web of Science ®Google Scholar
• Salyaev RK, Rekoslavskaya NI, Stolbikov AS, et al. Candidate mucosal vaccine against hepatitis B based on tomatoes transgenic for the preS2-S gene. Dokl Biochem Biophys 2012;446:257-9
   PubMed Web of Science ®Google Scholar
• Ma C, Wang L, Webster DE, et al. Production, characterization and immunogenicity of a plant-made Plasmodium antigen – the 19 kDa C-terminal fragment of Plasmodium yoelii merozoite surface protein 1. Appl Microbiol Biotechnol 2012;94(1):151-61
   PubMed Web of Science ®Google Scholar
• Chan HT, Chia MY, Pang VF, et al. Oral immunogenicity of porcine reproductive and respiratory syndrome virus antigen expressed in transgenic banana. Plant Biotechnol J 2013;11(3):315-24
   PubMed Web of Science ®Google Scholar
• Martínez-González L, Rosales-Mendoza S, Soria-Guerra RE, et al. Oral immunization with a lettuce-derived Escherichia coli heat-labile toxin B subunit induces neutralizing antibodies in mice. Plant Cell Tiss Organ Cult 2011;107:441-9
   Web of Science ®Google Scholar
• Pelosi A, Piedrafita D, De Guzman G, et al. The effect of plant tissue and vaccine formulation on the oral immunogenicity of a model plant-made antigen in sheep. PLoS One 2012;7(12):e52907
   PubMed Web of Science ®Google Scholar
• Ye YJ, Li WG. The study on immune responses in BALB/c mice by immunization with the transgenic alfalfa (Medicago sativa) containing Eg95-EgA31 fusion gene of Echinococcus granulosus. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2010;26(8):750-3
   PubMedGoogle Scholar
• Chia MY, Hsiao SH, Chan HT, et al. Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant. Vet Immunol Immunopathol 2010;135(3-4):234-43
   PubMed Web of Science ®Google Scholar
• Dreesen IA, Charpin El, Hamri G, et al. Heat-stable oral alga-based vaccine protects mice from Staphylcoccus aureus infection. J Biotechnol 2010;145(3):273-80
   PubMed Web of Science ®Google Scholar
• Kopertekh L, Broer I, Schiemann J. A developmentally regulated Cre- lox. In: Dunwell JM, Wetten CA, editors. Transgenic plants methods and protocols. School of Biological Sciences University of Reading, Humana Press; London, UK: 2012. p. 335-50
   Google Scholar
• Ebinuma H, Nanto K, Kasahara S, Komamine A. Marker-free gene targeting by recombinase-mediated cassette exchange. In: Dunwell JM, Wetten CA, editors. Transgenic plants methods and protocols. School of Biological Sciences University of Reading, Humana Press; London, UK: 2012. p. 377-90
   Google Scholar
• Wakasa Y, Takaiwa F. Use of a callus-specific selection system to develop transgenic rice seed accumulating a high level of recombinant protein. In: Dunwell JM, Wetten CA, editors. Transgenic plants methods and protocols. School of Biological Sciences University of Reading, Humana Press; London, UK: 2012. p. 467-79
   Google Scholar
• Ferradini N, Nicolia A, Capomaccio S, et al. Assessment of simple marker-free genetic transformation techniques in alfalfa. Plant Cell Rep 2011;30(11):1991-2000
   PubMed Web of Science ®Google Scholar
• Mátic S, Masenga V, Poli A, et al. Comparative analysis of recombinant Human Papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods. Plant Biotechnol J 2012;10(4):410-21
   PubMed Web of Science ®Google Scholar
• Matić S, Rinaldi R, Masenga V, Noris E. Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants. BMC Biotechnol 2011;11:106
   PubMed Web of Science ®Google Scholar
• Thuenemann EC, Lenzi P, Love AJ, et al. The use of transient expression systems for the rapid production of virus like particles in plants. Curr Pharm Des 2013;19(31):5564-73
   PubMed Web of Science ®Google Scholar
• Inka Borchers AM, Gonzalez-Rabade N, Gray JC. Increased accumulation and stability of rotavirus VP6 protein in tobacco chloroplasts following changes to the 5’ untranslated region and the 5’ end of the coding region. Plant Biotechnol J 2012;10(4):422-34
   PubMed Web of Science ®Google Scholar
• Gorantala J, Grover S, Rahl A, et al. Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine. J Biotechnol 2014;176:1-10
   PubMed Web of Science ®Google Scholar
• Yang Y, Li X, Yang H, et al. Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants. Sci China Life Sci 2011;54(1):82-9
   PubMed Web of Science ®Google Scholar
• Pniewski T, Kapusta J, Bociąg P, et al. Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablets formulation. J Appl Genet 2011;52(2):125-36
   PubMed Web of Science ®Google Scholar
• Lai H, Chen Q. Bioprocessing of plant-derived particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations. Plant Cell Rep 2012;31(3):573-84
   PubMed Web of Science ®Google Scholar
• Love AJ, Chapman SN, Matic S, et al. In planta production of a candidate vaccine against bovine papillomavirus type 1. Planta 2012;236(4):1305-13
   PubMed Web of Science ®Google Scholar
• Pniewski T, Kapusta J, Bociąg P, et al. Plant expression, lyophilisation and storage of HBV medium and large surface antigens for a prototype oral vaccine formulation. Plant Cell Rep 2012;31(3):585-95
   PubMed Web of Science ®Google Scholar
• Jones RM, Chischester JA, Mett V, et al. A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice. PLoS One 2013;8(11):e79538
   PubMed Web of Science ®Google Scholar
• Kessans SA, Linhart MD, Matoba N, Mor T. Biological and biochemical characterization of HIV-1 Gag/dgp41 virus-like particles expressed in Nicotiana benthamiana. Plant Biotechnol J 2013;11(6):681-90
   PubMed Web of Science ®Google Scholar
• Pineo CB, Hitzeroth II, Rybicki EP. Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimeras. Plant Biotechnol J 2013;11(8):964-75
   PubMed Web of Science ®Google Scholar
• Thuenemann EC, Meyers AE, Verwey J, et al. A method for rapid production of heteromultimeric protein complex in plants. Plant Biotechnol J 2013;11(7):839-46
   PubMed Web of Science ®Google Scholar
• Monroy-García A, Gómez-Lim MA, Weiss-Steider B, et al. Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model. Arch Virol 2014;159(2):291-305
   PubMed Web of Science ®Google Scholar